Keri S. Kim
Clinical Assistant Professor/Clinical Pharmacist, College of Pharmacy - Pharmacy Practice
Contact
Office Phone:
Email:
Related Sites:
About Heading link
Research Interests:
Thrombosis and hemostasis
Teaching and Supervision Heading link
Undergrad Resrch Pharm Pract (PMPR 380), 1/9/2023 – 4/28/2023
PDAT 3:Renal, Electro, Nutrtn (PHAR 503), 8/22/2022 – 12/2/2022
PMPR 380 Undergrad Resrch Pharm Pract (PMPR 380), 8/22/2022 – 12/9/2022
PDAT 3:Renal, Electro, Nutrtn (PHAR 503), 8/22/2022 – 12/2/2022
PMPR 380 Undergrad Resrch Pharm Pract (PMPR 380), 1/10/2022 – 5/13/2022
PMPR 390 Independent Study: Projects: Introduction to Medication History and Reconciliation (PMPR 390), 8/30/2021 – 12/3/2021
PMPR 380 Undergrad Resrch Pharm Pract (PMPR 380), 8/23/2021 – 12/3/2021
PMPR 380 Undergrad Resrch Pharm Pract (PMPR 380), 1/11/2021 – 5/14/2021
Advanced Specialty Training Program for HKHA: Anticoagulation reversal, Special Considerations for VTE Management in the Acute Setting, 12/1/2020 – Present
Selected Grants
COVID19 Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP), Global Coalition for Adaptive Research., 6/16/2021 - 8/31/2023, Obligated Amount: $175284; Anticipated Amount: $175284
COVID19 Novel Experimental COVID Therapies Affecting Host Response (NECTAR) ACTIV 4d RAAS, Vanderbilt University Medical Center., 3/1/2021 - 8/1/2022, Obligated Amount: $270316; Anticipated Amount: $270316
Convalescent Plasma To Limit Coronavirus Associated Complications: A Randomized Blinded Phase 2 Study Comparing The Efficacy And Safety Of Anti-Sars-Cov-2 Plasma To Placebo In Covid-19 Hospitalized Pa, New York University School of Medicine., 2/15/2021 - 5/14/2021, Obligated Amount: $22501; Anticipated Amount: $22501
COVID19 ACTIV-IV Post-Hospital Platform, University of Pittsburgh., 12/1/2020 - 11/30/2021, Obligated Amount: $886841.00; Anticipated Amount: $886841.00
COVID19 CTA: ACTIV-IV Post Hospital Platform, University of Pittsburgh., 12/1/2020 - 11/30/2022, Obligated Amount: $4277904; Anticipated Amount: $4277904
Thrombotic Complications in COVID-19 Pneumonia Compared to Bacterial Pneumonia and Viral Pneumonia, University of Illinois Health., 11/2/2020 - Present, No Obligated Amount Set; No Anticipated Amount Set
COVID19 A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitals Adults with COVID-19, New York University School of Medicine., 9/25/2020 - 12/31/2022, Obligated Amount: $254499; Anticipated Amount: $254499
CTA: COVID19 ACTIV-IV Inpatient Platform (ACTIV4a), University of Pittsburgh., 7/1/2020 - 5/31/2023, Obligated Amount: $1273013; Anticipated Amount: $1273013
Comparison of percent adjusted vs. predefined incremental argatroban dosing nomograms: more frequent monitoring does not improve time to therapeutic anticoagulation, University of Illinois Health., 7/1/2019 - 8/31/2021, No Obligated Amount Set; No Anticipated Amount Set
Selected Publications
Holden, DN, Mucksavage, JJ, Cokley, JA, Kim, KS, Tucker, NL, Esordi, MS, Cook, AM. (2023). Hypertonic saline use in neurocritical care for treating cerebral edema: A review of optimal formulation, dosing, safety, administration and storage. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 80, (6), 331-342. doi:10.1093/ajhp/zxac368.
Mainali, Shraddha, Aiyagari, Venkatesh, Alexander, Sheila, Bodien, Yelena, Boerwinkle, Varina, Boly, Melanie, Brown, Emery, Brown, Jeremy, Claassen, Jan, Edlow, Brian L, Fink, Ericka L, Fins, Joseph J, Foreman, Brandon, Frontera, Jennifer, Geocadin, Romergryko G, Giacino, Joseph, Gilmore, Emily J, Gosseries, Olivia, Hammond, Flora, Helbok, Raimund, Claude Hemphill, J, Hirsch, Karen, Kim, Keri, Laureys, Steven, Lewis, Ariane, Ling, Geoffrey, Livesay, Sarah L, McCredie, Victoria, McNett, Molly, Menon, David, Molteni, Erika, Olson, DaiWai, O’Phelan, Kristine, Park, Soojin, Polizzotto, Len, Javier Provencio, Jose, Puybasset, Louis, Venkatasubba Rao, Chethan P, Robertson, Courtney, Rohaut, Benjamin, Rubin, Michael, Sharshar, Tarek, Shutter, Lori, Sampaio Silva, Gisele, Smith, Wade, Stevens, Robert D, Thibaut, Aurore, Vespa, Paul, Wagner, Amy K, Ziai, Wendy C, Zink, Elizabeth, Suarez, Jose I. (2022). Correction to: Proceedings of the Second Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness. Neurocritical Care, 37, (2), 608-609. doi:10.1007/s12028-022-01536-w.
Olson, DWM, Hemphill, JC, Provencio, JJ, Vespa, P, Mainali, S, Polizzotto, L, Kim, KS, Mcnett, M, Ziai, W, Suarez, JI. (2022). The Curing Coma Campaign and the Future of Coma Research. Seminars in Neurology, 42, (3), 393-402. doi:10.1055/a-1887-7104.
Mainali, Shraddha, Aiyagari, Venkatesh, Alexander, Sheila, Bodien, Yelena, Boerwinkle, Varina, Boly, Melanie, Brown, Emery, Brown, Jeremy, Claassen, Jan, Edlow, Brian L, Fink, Ericka L, Fins, Joseph J, Foreman, Brandon, Frontera, Jennifer, Geocadin, Romergryko G, Giacino, Joseph, Gilmore, Emily J, Gosseries, Olivia, Hammond, Flora, Helbok, Raimund, Claude Hemphill, J, Hirsch, Karen, Kim, Keri, Laureys, Steven, Lewis, Ariane, Ling, Geoffrey, Livesay, Sarah L, McCredie, Victoria, McNett, Molly, Menon, David, Molteni, Erika, Olson, DaiWai, O’Phelan, Kristine, Park, Soojin, Polizzotto, Len, Javier Provencio, Jose, Puybasset, Louis, Venkatasubba Rao, Chethan P, Robertson, Courtney, Rohaut, Benjamin, Rubin, Michael, Sharshar, Tarek, Shutter, Lori, Sampaio Silva, Gisele, Smith, Wade, Stevens, Robert D, Thibaut, Aurore, Vespa, Paul, Wagner, Amy K, Ziai, Wendy C, Zink, Elizabeth, I Suarez, Jose. (2022). Proceedings of the Second Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness. Neurocritical Care, 37, (1), 326-350. doi:10.1007/s12028-022-01505-3.
Berger, JS, Kornblith, LZ, Gong, MN, Reynolds, HR, Cushman, M, Cheng, Y, McVerry, BJ, Kim, KS, Lopes, RD, Atassi, B, Berry, S, Bochicchio, G, De Oliveira Antunes, M, Farkouh, ME, Greenstein, Y, Hade, EM, Hudock, K, Hyzy, R, Khatri, P, Kindzelski, A, Kirwan, BA, Baumann Kreuziger, L, Lawler, PR, Leifer, E, Lopez-Sendon Moreno, J, Lopez-Sendon, J, Luther, JF, Nigro Maia, L, Quigley, J, Sherwin, R, Wahid, L, Wilson, J, Hochman, JS, Neal, MD. (2022). Effect of P2Y12 Inhibitors on Survival Free of Organ Support among Non-Critically Ill Hospitalized Patients with COVID-19: A Randomized Clinical Trial. JAMA, 327, (3), 227-236. doi:10.1001/jama.2021.23605.
Phan, B, Fagaragan, L, Alaraj, A, Kim, KS. (2022). Multidisciplinary Bundle Approach in Venous Thromboembolism Prophylaxis in Patients with Non-Traumatic Subarachnoid Hemorrhage. Clinical and Applied Thrombosis/Hemostasis, 28. doi:10.1177/10760296221074682.
Lawler, PR, Goligher, EC, Berger, JS, Neal, MD, McVerry, BJ, Nicolau, JC, Gong, MN, Carrier, M, Rosenson, RS, Reynolds, HR, Turgeon, AF, Escobedo, J, Huang, DT, Bradbury, CA, Houston, BL, Kornblith, LZ, Kumar, A, Kahn, SR, Cushman, M, McQuilten, Z, Slutsky, AS, Kim, KS, Gordon, AC, Kirwan, BA, Brooks, MM, Higgins, AM, Lewis, RJ, Lorenzi, E, Berry, SM, Berry, LR, Angus, DC, McArthur, CJ, Webb, SA, Farkouh, ME, Hochman, JS, Zarychanski, R, Aday, AW, Al-Beidh, F, Annane, D, Arabi, YM, Aryal, D, Kreuziger, LB, Beane, A, Bhimani, Z, Bihari, S, Billett, HH, Bond, L, Bonten, M, Brunkhorst, F, Buxton, M, Buzgau, A, Castellucci, LA, Chekuri, S, Chen, JT, Cheng, AC, Chkhikvadze, T, Coiffard, B, Costantini, TW, de Brouwer, S, Derde, LPG, Detry, MA, Duggal, A, Džavík, V, Effron, MB, Estcourt, LJ, Everett, BM, Fergusson, DA, Fitzgerald, M, Fowler, RA, Galanaud, JP, Galen, BT, Gandotra, S, García-Madrona, S, Girard, TD, Godoy, LC, Goodman, AL, Goossens, H, Green, C, Greenstein, YY, Gross, PL, Hamburg, NM, Haniffa, R, Hanna, G, Hanna, N, Hegde, SM, Hendrickson, CM, Hite, RD, Hindenburg, AA, Hope, AA, Horowitz, JM, Horvat, CM, Hudock, K, Hunt, BJ, Husain, M, Hyzy, RC, Iyer, VN, Jacobson, JR, Jayakumar, D, Keller, NM, Khan, A. (2021). Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19. New England Journal of Medicine, 385, (9), 790-802. doi:10.1056/NEJMoa2105911.
Goligher, EC, Bradbury, CA, McVerry, BJ, Lawler, PR, Berger, JS, Gong, MN, Carrier, M, Reynolds, HR, Kumar, A, Turgeon, AF, Kornblith, LZ, Kahn, SR, Marshall, JC, Kim, KS, Houston, BL, Derde, LPG, Cushman, M, Tritschler, T, Angus, DC, Godoy, LC, McQuilten, Z, Kirwan, BA, Farkouh, ME, Brooks, MM, Lewis, RJ, Berry, LR, Lorenzi, E, Gordon, AC, Berry, SM, McArthur, CJ, Neal, MD, Hochman, JS, Webb, SA, Zarychanski, R, Ahuja, T, Al-Beidh, F, Annane, D, Arabi, YM, Aryal, D, Kreuziger, LB, Beane, A, Bhimani, Z, Bihari, S, Billett, HH, Bond, L, Bonten, M, Brunkhorst, F, Buxton, M, Buzgau, A, Castellucci, LA, Chekuri, S, Chen, JT, Cheng, AC, Chkhikvadze, T, Coiffard, B, Contreras, A, Costantini, TW, de Brouwer, S, Detry, MA, Duggal, A, Džavík, V, Effron, MB, Eng, HF, Escobedo, J, Estcourt, LJ, Everett, BM, Fergusson, DA, Fitzgerald, M, Fowler, RA, Froess, JD, Fu, Z, Galanaud, JP, Galen, BT, Gandotra, S, Girard, TD, Goodman, AL, Goossens, H, Green, C, Greenstein, YY, Gross, PL, Haniffa, R, Hegde, SM, Hendrickson, CM, Higgins, AM, Hindenburg, AA, Hope, AA, Horowitz, JM, Horvat, CM, Huang, DT, Hudock, K, Hunt, BJ, Husain, M, Hyzy, RC, Jacobson, JR, Jayakumar, D, Keller, NM, Khan, A, Kim, Y, Kindzelski, A, King, AJ. (2021). Therapeutic anticoagulation with heparin in critically ill patients with covid-19. New England Journal of Medicine, 385, (9), 777-789. doi:10.1056/NEJMoa2103417.
Jao, M, Wenzler, E, Kim, KS. (2021). Comparison of percent adjusted versus predefined incremental argatroban dosing nomograms in patients with heparin induced thrombocytopenia. Thrombosis Update, 4. doi:10.1016/j.tru.2021.100060.
Professional Leadership
2022 NCS/CCC World Coma Day, Neurocritical Care Society/Curing Coma Campaign, 9/1/2021 - 3/22/2022
Neurocritical Care Society (NCS) Guidelines Committee, Neurocritical Care Society (NCS), 10/1/2020 - 9/30/2024
Neurocritical Care Research Network (NCRN), Neurocritical Care Society (NCS), 1/1/2020 - Present
Pharmacy Residency Research Committee, UIC COP, University of Illinois at Chicago, 7/1/2018 - Present
Neurocritical Care Society (NCS) Research Operations Sub-Committee, Neurocritical Care Society (NCS), 10/1/2017 - 9/30/2021
Neurosurgery Intensive Care Unit Quality Improvement Committee, UI Health, University of Illinois Hospital & Health Sciences System, 1/1/2015 - Present
Anticoagulation Quality Improvement Committee, UI Health, University of Illinois Hospital & Health Sciences System, 8/1/2011 - Present
Pharmacy Residency Research Committee, UIC COP, University of Illinois at Chicago, 7/1/2011 - 6/30/2018
Notable Honors
2022, 2022 Presidential Citation Award, Neurocritical Care Society
2022, 2022 Fellow of Neurocritical Care Society (FNCS), Neurocritical Care Society
2020, 2020 Presidential Citation Award, Neurocritical Care Society
Education
Degrees:
Master of Science in Clinical and Translation Science (MS CTS), University of Illinois at Chicago, United States, 2010
Doctor of Pharmacy, University of Illinois at Chicago, United States, 2003
Pre-Pharmacy Curriculum, University of Illinois at Chicago, United States, 1999
Postgraduate Training:
Critical Care Specialty Resident, Virginia Commonwealth University, United States, 2005
Pharmacy Practice Resident, University of Illinois at Chicago College of Pharmacy, United States, 2004
Licensures and Certifications
Board Certified Pharmacotherapy Specialist, American College of Clinical Pharmacy, 11/2005 - Present
Teaching Certificate Program, University of Illinois at Chicago, 7/2004 - Present
Advanced Cardiac Life Support Provider, American Heart Association, 7/2003 - Present
Basic Life Support Provider, American Heart Association, 1/2003 - Present
Pharmacists-Based Immunization Delivery, American Pharmacists Association Foundation, 1/2003 - Present
Pharmacist, Illinois Board of Pharmacy, 8/2003 - Present
Pharmacist, Virginia Board of Pharmacy, 8/2004 - 12/2005
Pharmacist, Texas Board of Pharmacy, 3/2019 - Present
Selected Presentations
Kim, Keri, Hwang, David, Meixensberger, Juergen. (2022 January 20). Neuroprognostication Guideline – Intracerebral Hemorrhage. 2022 Arbeitstagung NeuroIntensivMedizin (ANIM) Meeting (A collaboration between Neurocritical Care Society and German Neurological Society of Neuro- Intensive Care and Emergency Medicine). Virual (Germany).